ArticleFrontiers in oncology2022

Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?

Daniele Fanale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.